The Trump administration on Wednesday sued the drug manufacturer Gilead Sciences, which sells a landmark HIV drug touted as one of the most important mechanisms to stop the spread of the virus across the nation.
Researchers at the Centers for Disease Control and Prevention spent years working on a treatment regimen using Truvada to stop the spread of HIV, funded by about $50 million in taxpayer money, according to a March report from The Washington Post. Gilead donated Truvada to the government to use in its testing.
However, Gilead has rebuffed attempts by the government to request that the company license the treatment regimen and contended that the government’s patent is invalid. In August, Gilead also filed a petition with the U.S. Patent and Trademark Office challenging the government’s patent.
Garbage misleading headline again
great click bait headline. Makes it seem that the suit is evil when the article says it may help lower the cost of the drug.